Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 27, member D1 pseudogene (ENSG00000279783) is annotated as a pseudogene—a genetic element derived from a once-functional gene that has sustained disabling mutations or retrotransposition events rendering it non-coding and typically non-functional at the protein level. Pseudogenes may occasionally be transcribed, and increasing evidence suggests that some pseudogenes can play **regulatory roles** in gene networks, including functioning as microRNA decoys or affecting regulatory RNA pools. However, this particular locus is not considered a therapeutic target, receptor, enzyme, or biomarker, and does not interact with drugs or participate in recognized disease mechanisms. As a pseudogene, its primary relevance is in genomic annotation, evolutionary studies, and potentially in regulatory RNA biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 27, member D1 pseudogene.